KEY TAKEAWAYS The NeoFox phase II trial aimed to assess the feasibility and efficacy of a neo-adjuvant treatment regimen in pts with stage II/III colon cancer. The Ad hoc observations suggested Foxy-5 impairs invasion and induces downstaging in stage II/III colon...